Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407363
Max Phase: Preclinical
Molecular Formula: C24H39N3O5
Molecular Weight: 449.59
Molecule Type: Protein
Associated Items:
ID: ALA2407363
Max Phase: Preclinical
Molecular Formula: C24H39N3O5
Molecular Weight: 449.59
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](NC(=O)[C@H](CC(C)C)N(C)C)[C@@H](O)c1ccccc1)C(=O)OC
Standard InChI: InChI=1S/C24H39N3O5/c1-8-16(4)19(24(31)32-7)25-23(30)20(21(28)17-12-10-9-11-13-17)26-22(29)18(27(5)6)14-15(2)3/h9-13,15-16,18-21,28H,8,14H2,1-7H3,(H,25,30)(H,26,29)/t16-,18-,19-,20+,21-/m0/s1
Standard InChI Key: CWOGOZGTBWESNI-BWUHRYBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 449.59 | Molecular Weight (Monoisotopic): 449.2890 | AlogP: 1.89 | #Rotatable Bonds: 12 |
Polar Surface Area: 107.97 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.08 | CX Basic pKa: 7.80 | CX LogP: 2.63 | CX LogD: 2.09 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: 0.42 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):